Kidney Stones Flashcards

1
Q

___ weather increases stone formation

A

hot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

____% recurrence risk at 5 years

A

50-60

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Immobilization leads to hyper____

A

hypercalciuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

_____ imaging prior to PCNL

A

Non-con CT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MUST obtain ____ before intervention to stratify infection risk

A

UA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ureteral stones <10mm distally should be offered ____

A

alpha-blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Re-imaging prior to surgery if stone ____ OR would change management

A

moved/passed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Offer stone treatment if MET is not successful after ____

A

4- weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

____ is the procedure with lowest morbidity & complication rate

A

ESWL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

1st line therapy for mid or distal ureteral stones - ____

A

URS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

____ is recommended to treat cystine or uric acid ureteral stones

A

URS

Cystine - not well broken down by ESWL

Uric Acid - radiolucent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Reasons to not stent

  1. No ____ injury
  2. No ____ stricture
  3. _____ contralateral kidney
  4. ____ AKI
  5. No planned 2nd stage URS
A
  1. No ureteral injury
  2. No ureteral stricture
  3. Normal contralateral kidney
  4. No AKI
  5. No planned 2nd stage URS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pre-stenting should ____ be performed

A

NOT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Meds for stent discomfort

A

alpha-blocker

anti-muscarinics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

With infection the first priority is _____

A

decompression of upper tract with stent vs PCN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

In patients with <20mm of non-lower pole stones, you can offer ___ OR ____

A

ESWL or URS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Total stone burden >2 cm should be treated with ____

A

PCNL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

For symptomatic, non-obstructing stones, you can off ____

A

stone treatment

19
Q

May perform ____ when stone filled kidney has negligible function

A

nephrectomy

20
Q

Offer ___ or ___ with symptomatic, <10mm lower pole stones

A

ESWL or URS

21
Q

NTs are ____ in uncomplicated PCNLs

A

optional

22
Q

Use ___ for irrigation for PCNL & URS

A

normal saline

23
Q

May prescribe ____ to facilitate stone passage s/p ESWL

A

alpha-blocker

24
Q

Do NOT use ____ with pts who have anatomic or functional obstruction

A

ESWL

25
Q

____ stones should be treated regardless of symptoms

A

Staghorn

26
Q

Children always need metabolic evaluation with a ____

A

24 hr urine

27
Q

In pediatrics with total stones >20 mm, you can offer ___ or ____ with pre-stenting

A

PCNL

ESWL with pre-stenting

no distinction between lower pole

28
Q

In pregnant pts with ureteral stones, you can offer ____ to pts who fail observation

A

URS

29
Q

Safest time for stone surgery in pregnancy is ____ trimester

A

2nd

30
Q

When fragments are present, should offer ____ treatment to render stone free

A

endoscopic

31
Q

Abort procedure and obtain culture if ____ urine is encountered

A

purulent

32
Q

In anti-coagulated pts, ____ is 1st line stone therapy

A

URS

33
Q

Skin to stone distance >____cm is associated with SWL failure

A

10

34
Q

BMI >____ may prohibit ESWL

A

30

35
Q

Treatment for 1.8cm lower pole stone in horseshoe kidney

A

PCNL

36
Q

With ruptured calyx, you can ____

A

observe

37
Q

Stones resistant to ESWL

A

CaOx Monohydrate
Brushite
Cystine

38
Q

Risk factors for uric acid stone formation

A

T2DM

Obesity

39
Q

Risk factors for hydroxyapatite stone formation

A

RTA
HyperPTH
Medullary sponge kidney
Carbonic anhydrase inhibitor

40
Q

Pharmacologic therapy for hypercalciuria

A

Thiazide diuretic

41
Q

Pharmacologic therapy for hyperuricosuria

A

Allopurinol

in recurrent Ca++ stone formers

42
Q

Pharmacologic therapy for hypocitraturia

A

Potassium Citrate

43
Q

Repeat 24 hr urine s/p ____ of dietary or medical intervention

A

6 months